sulbactam and rifampin
sulbactam has been researched along with rifampin in 30 studies
Compound Research Comparison
| Studies (sulbactam) | Trials (sulbactam) | Recent Studies (post-2010) (sulbactam) | Studies (rifampin) | Trials (rifampin) | Recent Studies (post-2010) (rifampin) |
|---|---|---|---|---|---|
| 1,844 | 297 | 488 | 20,468 | 1,499 | 6,552 |
Protein Interaction Comparison
| Protein | Taxonomy | sulbactam (IC50) | rifampin (IC50) |
|---|---|---|---|
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.949 | |
| Caspase-1 | Homo sapiens (human) | 8.319 | |
| Alpha-synuclein | Homo sapiens (human) | 7.1 | |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 0.03 | |
| DNA-directed RNA polymerase subunit beta | Mycobacterium tuberculosis H37Rv | 0.01 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.5 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.5 |
Research
Studies (30)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (20.00) | 18.2507 |
| 2000's | 12 (40.00) | 29.6817 |
| 2010's | 11 (36.67) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Bauraing, C; Bogaerts, P; Cuzon, G; Deplano, A; Glupczynski, Y; Lissoir, B; Naas, T; Nordmann, P | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Docobo-Pérez, F; Domínguez-Herrera, J; García-Curiel, A; Jiménez, L; Jiménez-Mejias, ME; López-Rojas, R; Pachón, J; Pachón-Ibáñez, ME; Pichardo, C | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Borchelt, MD; Francis, SJ; Kremer, RM; Levy, RP; O'Connor, CA | 1 |
| Chambers, HF; Kartalija, M; Sande, M | 1 |
| Herbert, D; Kubendiran, G; Mitchison, DA; Paramasivan, CN; Prabhakar, R; Venkatesan, P | 1 |
| Canawati, HN; Montgomerie, JZ; Schick, DG | 1 |
| Bistoni, F; Bozza, S; Del Favero, A; Menichetti, F; Tascini, C | 1 |
| Aeschlimann, JR; Hershberger, E; Moldovan, T; Rybak, MJ | 1 |
| Dudzevicius, V; Sakalauskas, R; Vitkauskiene, A | 1 |
| Aparicio, I; Bello, MA; Callejón, M; Guiraúm, A | 1 |
| Docobo-Pérez, F; Fernández-Cuenca, F; Pachón, J; Pachón-Ibáñez, ME; Pascual, A | 1 |
| Apisarnthanarak, A; Mundy, LM | 1 |
| Cassone, A; Di Sora, F; Dionisi, AM; Gallo, S; Longo, B; Luzzi, I; Monaco, M; Montella, F; Pantosti, A; Placanica, P; Rezza, G; Tarasi, A; Volpe, I | 1 |
| Cheong, HJ; Hwang, IS; Jeong, HW; Kee, SY; Kim, WJ; Seo, YB; Song, JY | 1 |
| Durante-Mangoni, E; Fortunato, R; Tripodi, MF; Utili, R; Zarrilli, R | 1 |
| Pachón, J; Vila, J | 1 |
| Akduman, D; Aktaş, E; Aydemir, H; Bektaş, S; Büyükateş, M; Celebi, G; Doğan, SM; Keskin, A; Oztoprak, N; Pişkin, N | 1 |
| Docobo-Pérez, F; García-Curiel, A; Ibáñez-Martínez, J; Jiménez-Mejias, ME; Pachón, J; Pachón-Ibáñez, ME; Pichardo, C | 1 |
| Clec'h, C; Cohen, Y; Jauréguy, F; Mellon, G; Picard, B | 1 |
| Bahador, A; Hashemizadeh, Z; Mansoori, N; Pourakbari, B; Raoofian, R; Rostami, H; Taheri, M | 1 |
| Chen, F; Dong, X; Liu, H; Liu, Y; Ma, L; Zhang, Y | 1 |
| Li, J; Liu, Y; Wei, W; Yang, H; Ye, Y | 1 |
| Abouelfetouh, A; El-Nakeeb, M; Kassem, M; Naguib, M | 1 |
| Cong, Y; Fan, B; Guan, J; Wang, X | 1 |
| Bedenic, B; Bogdan, M; Drenjancevic, D; Harsanji Drenjancevic, I; Talapko, J; Vukovic, D; Zujic Atalic, V | 1 |
| Balasubramanium, G; Elangovan, R; Gupta, SS; Lodha, T; Muthulakshmi, T; Perumal, V; Sivaraman, GK; Visnuvinayagam, S; Yadav, A | 1 |
Reviews
1 review(s) available for sulbactam and rifampin
| Article | Year |
|---|---|
Therapeutic options for Acinetobacter baumannii infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Minocycline; Patient Selection; Rifampin; Sulbactam; Tigecycline; Treatment Outcome | 2008 |
Other Studies
29 other study(ies) available for sulbactam and rifampin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Carbapenem-resistant Acinetobacter baumannii isolates expressing the blaOXA-23 gene associated with ISAba4 in Belgium.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Belgium; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Genes, Bacterial; Humans | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Meningitis, Bacterial; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rabbits; Rifampin; Sulbactam; Treatment Outcome | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Hemophilus influenza infection of an implantable insulin-pump pocket.
Topics: Adult; Ampicillin; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Insulin Infusion Systems; Rifampin; Sulbactam | 1992 |
Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
Topics: Ampicillin; Animals; Aortic Valve; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Vancomycin | 1995 |
Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Drug Therapy, Combination; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Penicillins; Rifampin; Sulbactam | 1996 |
In vitro activity of the combination of trovafloxacin and other antibiotics against enterococci.
Topics: Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus; Enterococcus faecalis; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Naphthyridines; Novobiocin; Rifampin; Sulbactam; Teicoplanin; Vancomycin | 1997 |
Evaluation of the activities of two-drug combinations of rifampicin, polymyxin B and ampicillin/sulbactam against Acinetobacter baumannii.
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Polymyxin B; Rifampin; Sulbactam | 1998 |
Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by
Topics: Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Drug Therapy, Combination; Fluoroquinolones; Gentamicins; Glycopeptides; Lipoglycopeptides; Microbial Sensitivity Tests; Naphthyridines; Rifampin; Staphylococcus aureus; Sulbactam; Teicoplanin; Time Factors; Vancomycin; Virginiamycin | 1999 |
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bronchoalveolar Lavage Fluid; Ceftazidime; Cefuroxime; Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fusidic Acid; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Staphylococcus aureus; Sulbactam; Vancomycin Resistance | 2003 |
Simultaneous determination of rifampicin and sulbactam in mouse plasma by high-performance liquid chromatography.
Topics: Animals; Chromatography, High Pressure Liquid; Mice; Mice, Inbred C57BL; Reproducibility of Results; Rifampin; Sulbactam | 2006 |
Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Imipenem; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mutation; Pneumonia, Bacterial; Rifampin; Sulbactam | 2006 |
Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
Topics: Anti-Bacterial Agents; Cefoperazone; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Humans; Male; Methicillin Resistance; Middle Aged; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Sulbactam | 2007 |
Molecular findings and antibiotic-resistance in an outbreak of Acinetobacter baumannii in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; Disinfection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Intensive Care Units; Male; Middle Aged; Patient Isolation; Rifampin; Rome; Sulbactam | 2007 |
In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Colony Count, Microbial; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; Sulbactam; Tigecycline | 2007 |
Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Drug Synergism; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Italy; Microbial Sensitivity Tests; Rifampin; Sulbactam | 2007 |
[Necrotising endocarditis of mitral valve due to Staphylococcus lugdunensis].
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Bacteremia; Chemotherapy, Adjuvant; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Heart Valve Prosthesis Implantation; Humans; Male; Mitral Valve; Necrosis; Rifampin; Staphylococcal Infections; Staphylococcus; Sulbactam; Ultrasonography; Vancomycin | 2009 |
Efficacy of rifampin, in monotherapy and in combinations, in an experimental murine pneumonia model caused by panresistant Acinetobacter baumannii strains.
Topics: Acinetobacter baumannii; Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Imipenem; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microbial Viability; Pneumonia, Bacterial; Rifampin; Rodent Diseases; Sulbactam; Treatment Outcome | 2011 |
Postsurgical meningitis due to multiresistant Acinetobacter baumannii successfully treated with high doses of ampicillin/sulbactam combined with rifampicin and fosfomycin.
Topics: Accidents, Traffic; Acinetobacter baumannii; Acinetobacter Infections; Adult; Ampicillin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Fosfomycin; Humans; Male; Meningitis, Bacterial; Postoperative Complications; Rifampin; Sulbactam | 2012 |
Emergence of rifampicin, tigecycline, and colistin-resistant Acinetobacter baumannii in Iran; spreading of MDR strains of novel International Clone variants.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Typing Techniques; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Iran; Microbial Sensitivity Tests; Minocycline; Multiplex Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prevalence; Rifampin; Sulbactam; Tertiary Healthcare; Tigecycline; Tobramycin | 2013 |
In vitro activities of rifampin, colistin, sulbactam and tigecycline tested alone and in combination against extensively drug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Minocycline; Rifampin; Sulbactam; Tigecycline | 2014 |
In vitro synergy of colistin combinations against extensively drug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Colistin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Humans; Imipenem; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Polymerase Chain Reaction; Rifampin; Sulbactam | 2016 |
Investigation and Treatment of Fusidic Acid Resistance Among Methicillin-Resistant Staphylococcal Isolates from Egypt.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Conjugation, Genetic; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Egypt; Fusidic Acid; Gene Expression Regulation, Bacterial; Gentamicins; Humans; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Plasmids; Rifampin; Staphylococcal Infections; Sulbactam | 2017 |
Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Fusidic Acid; Meropenem; Mice; Microbial Sensitivity Tests; Minocycline; Rifampin; Sulbactam; Thienamycins; Tigecycline | 2016 |
In vitro effect of subminimal inhibitory concentrations of antibiotics on the biofilm formation ability of Acinetobacter baumannii clinical isolates.
Topics: Acinetobacter baumannii; Ampicillin; Anti-Bacterial Agents; Azithromycin; Biofilms; Colistin; Imipenem; Microbial Sensitivity Tests; Rifampin; Sulbactam | 2018 |
Prevalence of S. aureus and/or MRSA from seafood products from Indian seafood products.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefoxitin; Gentamicins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Ofloxacin; Piperacillin; Prevalence; Rifampin; Seafood; Serine; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination; Virulence Factors | 2022 |